Your browser doesn't support javascript.
loading
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences.
Barreca, Marilia; Lang, Noémie; Tarantelli, Chiara; Spriano, Filippo; Barraja, Paola; Bertoni, Francesco.
Afiliação
  • Barreca M; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90123 Palermo, Italy.
  • Lang N; Division of Oncology, Department of Oncology, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Barraja P; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90123 Palermo, Italy.
  • Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
Explor Target Antitumor Ther ; 3(6): 763-794, 2022.
Article em En | MEDLINE | ID: mdl-36654819
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália